Sacral neuromodulation in overactive bladder: a review and current perspectives

References

• AbramsPDescribing bladder storage function: overactive bladder syndrome and detrusor overactivityUrology2003625 suppl 22837 discussion 40–4214662404
   PubMed Web of Science ®Google Scholar
• AbramsPCardozoLFallMStandardisation Sub-committee of the International Continence SocietyThe standardisation of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence SocietyNeurourol Urodyn200221216717811857671
   PubMed Web of Science ®Google Scholar
• NittiVWThe prevalence of urinary incontinenceRev Urol20013suppl 1S2S6
   PubMedGoogle Scholar
• StewartWFVan RooyenJBCundiffGWPrevalence and burden of overactive bladder in the United StatesWorld J Urol200320632733612811491
   PubMed Web of Science ®Google Scholar
• MilsomIAbramsPCardozoLRobertsRGThüroffJWeinAJHow widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence studyBJU Int200187976076611412210
   PubMed Web of Science ®Google Scholar
• SandvikHHunskaarSSeimAHermstadRVanvikABrattHValidation of a severity index in female urinary incontinence and its implementation in an epidemiological surveyJ Epidemiol Community Health19934764974998120507
   PubMed Web of Science ®Google Scholar
• SandvikHFemale urinary incontinence: studies of epidemiology and management in general practice [thesis]BergenUniversity of Bergen1995
   Google Scholar
• CoyneKSWeinANicholsonSKvaszMChenCIMilsomIEconomic burden of urgency urinary incontinence in the United States: a systematic reviewJ Manag Care Pharm201420213014024456314
   PubMed Web of Science ®Google Scholar
• SchmidtRAJonasUOlesonKASacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study GroupJ Urol1999162235235710411037
   PubMed Web of Science ®Google Scholar
• AmundsenCLRomeroAAJamisonMGWebsterGDSacral neuromodulation for intractable urge incontinence: are there factors associated with cure?Urology200566474675016230129
   PubMed Web of Science ®Google Scholar
• SiegelSWCatanzaroFDijkemaHELong-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retentionUrology2000566 suppl 18791
   PubMed Web of Science ®Google Scholar
• TanaghoEASchmidtRAElectrical stimulation in the clinical management of the neurogenic bladderJ Urol19881406133113393057221
   PubMed Web of Science ®Google Scholar
• SpinelliMSSievertKDLatest technologic and surgical developments in using InterStim therapy for sacral neuromodulation: impact on treatment success and safetyEur Urol20085461287129618336992
   PubMed Web of Science ®Google Scholar
• ScheepensWAWeilEHvan KoeveringeGARohrmannDHedlundHESchurchBButtock placement of the implantable pulse generator: a new implantation technique for sacral neuromodulation – a multicenter studyEur Urol200140443443811713399
   PubMed Web of Science ®Google Scholar
• BartleyJGilleranJPetersKNeuromodulation for overactive bladderNat Rev Urol201310951352123817408
   PubMed Web of Science ®Google Scholar
• PhamKGuralnickMLO’ConnorRCUnilateral versus bilateral stage I neuromodulator lead placement for the treatment of refractory voiding dysfunctionNeurourol Urodyn200827877978118551562
   PubMed Web of Science ®Google Scholar
• ScheepensWAde BieRAWeilEHvan KerrebroeckPEUnilateral versus bilateral sacral neuromodulation in patients with chronic voiding dysfunctionJ Urol200216852046205012394705
   PubMed Web of Science ®Google Scholar
• LengWWChancellorMBHow sacral nerve stimulation neuromodulation worksUrol Clin North Am2005321111815698871
   PubMed Web of Science ®Google Scholar
• KohliNPattersonDInterStim therapy: a contemporary approach to overactive bladderRev Obstet Gynecol200921182719399291
   PubMedGoogle Scholar
• LatiniJMAlipourMKrederKJJrEfficacy of sacral neuromodulation for symptomatic treatment of refractory urinary urge incontinenceUrology2006673550553 discussion 553–55416527577
   PubMed Web of Science ®Google Scholar
• van KerrebroeckPEvan VoskuilenACHeesakkersJPResults of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical studyJ Urol200717852029203417869298
   PubMed Web of Science ®Google Scholar
• Chartier-KastlerEJRuud BoschJLPerrigotMChancellorMBRichardFDenysPLong-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexiaJ Urol200016451476148011025686
   PubMed Web of Science ®Google Scholar
• HassounaMMSiegelSWNÿeholtAASacral neuromodulation in the treatment of urgency-frequency symptoms: a multicenter study on efficacy and safetyJ Urol200016361849185410799197
   PubMed Web of Science ®Google Scholar
• PetersKMKandagatlaPKillingerKAWolfertCBouraJAClinical outcomes of sacral neuromodulation in patients with neurologic conditionsUrology201381473874323537757
   PubMed Web of Science ®Google Scholar
• ShermanNDJamisonMGWebsterGDAmundsenCLSacral neuromodulation for the treatment of refractory urinary urge incontinence after stress incontinence surgeryAm J Obstet Gynecol200519362083208716325620
   PubMed Web of Science ®Google Scholar
• StarkmanJSWolterCEScarperoHMMilamDFDmochowskiRRManagement of refractory urinary urge incontinence following urogynecological surgery with sacral neuromodulationNeurourol Urodyn20062612935 discussion 36
   Web of Science ®Google Scholar
• WhiteWMMobleyJD3rdDoggweilerRDobmeyer-DittrichCKleinFAIncidence and predictors of complications with sacral neuromodulationUrology200973473173519193415
   PubMed Web of Science ®Google Scholar
• WisemanOJv d HomberghUKoldewijnELSpinelliMSiegelSWFowlerCJSacral neuromodulation and pregnancyJ Urol20011671165168
   Web of Science ®Google Scholar
• Medtronic [webpage on the Internet]Important Safety Information Available from: http://www.medtronic.com/patients/overactive-bladder/important-safety-information/index.htmAccessed February 10, 2012
   Google Scholar
• AboseifSRKimDHRiederJMSacral neuromodulation: cost considerations and clinical benefitsUrology200770610691073 discussion 1073–107418158016
   PubMed Web of Science ®Google Scholar
• SiddiquiNYAmundsenCLViscoAGMyersERWuJMCost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinenceJ Urol200918262799280419837427
   PubMed Web of Science ®Google Scholar
• FreemantleNKhalafKLovemanCOnabotulinumtoxinA in the treatment of overactive bladder: a cost-effectiveness analysis versus best supportive care in England and WalesEur J Health Econ Epub20151019
   Web of Science ®Google Scholar
• BertapelleMPVotteroMPopoloGDSacral neuromodulation and Botulinum toxin A for refractory idiopathic overactive bladder: a cost-utility analysis in the perspective of Italian Healthcare SystemWorld J Urol20143381109111725218855
   PubMed Web of Science ®Google Scholar
• ArlandisSCastroDErrandoCCost-effectiveness of sacral neuromodulation compared to botulinum neurotoxin a or continued medical management in refractory overactive bladderValue Health201114221922821402292
   PubMed Web of Science ®Google Scholar
• SacristánJAOlivaJDel LlanoJPrietoLPintoJL¿Qué es una tecnología sanitaria eficiente en España? [What is an efficient health technology in Spain?]Gac Sanit2002164334343 Spanish12113733
   PubMedGoogle Scholar